FBTCX Holdings Information

FBTCX is a mutual fund with a total of 92 individual holdings. The top holdings are AbbVie stock at 16.55%, Gilead Sciences at 6.38%, Alnylam Pharmaceuticals at 5.94%, Cogent Biosciences at 4.06%, and Insmed at 3.84%.

Total Holdings

Top 10 Percentage

52.62%

Asset Class

Equity

Fund Category

Health

Assets

1.87B

Forward PE Ratio

19.29

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ABBV	AbbVie Inc.	16.55%	1,356,480
2	GILD	Gilead Sciences, Inc.	6.38%	814,800
3	ALNY	Alnylam Pharmaceuticals, Inc.	5.94%	339,486
4	COGT	Cogent Biosciences, Inc.	4.06%	1,988,418
5	INSM	Insmed Incorporated	3.84%	489,600
6	ASND	Ascendis Pharma A/S	3.78%	308,225
7	ARGX	argenx SE	3.27%	81,000
8	AMGN	Amgen Inc.	3.08%	150,703
9	BIIB	Biogen Inc.	2.97%	294,100
10	VRDN	Viridian Therapeutics, Inc.	2.75%	1,782,464
11	PCVX	Vaxcyte, Inc.	2.58%	796,329
12	NUVL	Nuvalent, Inc.	2.21%	412,264
13	DNTH	Dianthus Therapeutics, Inc.	2.12%	730,062
14	AMLX	Amylyx Pharmaceuticals, Inc.	1.94%	2,433,200
15	SYRE	Spyre Therapeutics, Inc.	1.92%	847,389
16	MRNA	Moderna, Inc.	1.90%	674,300
17	APGE	Apogee Therapeutics, Inc.	1.67%	452,639
18	XENE	Xenon Pharmaceuticals Inc.	1.62%	710,758
19	GPCR	Structure Therapeutics Inc.	1.59%	481,200
20	ROIV	Roivant Sciences Ltd.	1.49%	976,200
21	PRAX	Praxis Precision Medicines, Inc.	1.39%	78,500
22	ORKA	Oruka Therapeutics, Inc.	1.29%	710,786
23	EBR: UCB	UCB SA	1.19%	75,800
24	CRNX	Crinetics Pharmaceuticals, Inc.	1.18%	544,470
25	VKTX	Viking Therapeutics, Inc.	1.15%	647,387

Showing 25 of 92 holdings

Subscribe to see the full list

Activate Now

As of Feb 28, 2026